Cargando…
Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?
Mesenchymal stromal cells (MSCs) have been found to be safe and effective in a wide range of animal models of human disease. MSCs have been tested in thousands of clinical trials, but results show that while these cells appear to be safe, they tend to lack efficacy. This has raised questions about w...
Autores principales: | Amadeo, Francesco, Trivino Cepeda, Katherine, Littlewood, James, Wilm, Bettina, Taylor, Arthur, Murray, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589440/ https://www.ncbi.nlm.nih.gov/pubmed/34495324 http://dx.doi.org/10.1042/ETLS20210013 |
Ejemplares similares
-
Mechanisms of T-Cell Immunosuppression by Mesenchymal Stromal Cells: What Do We Know So Far?
por: Haddad, Rodrigo, et al.
Publicado: (2014) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022) -
The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013) -
Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)